Drug discount cards could actually cost patients more
New research co-authored by CHÉOS Scientist Dr. Mark Harrison reveals that brand-name drug discount cards may be leading to higher health care spending in Canada.
Read MoreApril 30, 2019
Data and research that provides insight into the economics of health policies and practices is vital to help governments and policymakers make decisions about spending while balancing tradeoffs. CHÉOS investigators are leaders in this field. Their work has been instrumental in informing budgets, health care policies, and guidelines at all levels of government.
New research co-authored by CHÉOS Scientist Dr. Mark Harrison reveals that brand-name drug discount cards may be leading to higher health care spending in Canada.
Read More
A $2.5 million project called ‘PRECISION’ is underway. It will study more than a million Canadians with inflammatory diseases of the skin, joint or bowel
Read More
The GenCOUNSEL project aims to figure out the best ways to provide equitable access to genetic counselling for genome-wide sequencing in Canada.
Read More
A recent study led by CHÉOS investigators has highlighted the impact of different chronic health conditions on missed workdays and employee productivity in Canada.
Read More
February 29 is Rare Disease Day. CHÉOS Scientist Dr. Larry Lynd and his colleagues are collaborating with the UBC Graduate School of Journalism on a new project.
Read More